Aflac Incorporated
Every calculator, already run for AFL
Open the full toolkit →You have the numbers on AFL. Get the argument.
A written report on which of these readings actually decide the outcome for Aflac Incorporated, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
15 analysts covering AFLAnalyst Price Target Disagreement for Aflac Incorporated
Wall Street's bull case implies +20% from the current price; the bear case implies -14%. A 34% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for AFL
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafete…
AFL — frequently asked
Is AFL a buy right now?
Wall Street's consensus rating on Aflac Incorporated is none across 15 analysts, with a mean price target of $118.53 (+3% vs. the current $115.28). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is AFL overvalued?
AFL trades at 12.4x trailing earnings, against a DCF fair value of $349 per share. The current price implies -8% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is AFL's next earnings date?
Aflac Incorporated is next scheduled to report earnings around Nov 4, 2026. A full AFL research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Aflac Incorporated?
Analysts covering Aflac Incorporated (AFL) range from a bear-case target of $99.00 to a bull-case high of $138.00, with a mean consensus target of $118.53 across 15 analysts. The spread of $39.00 (34% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Aflac Incorporated against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Aflac Incorporated
Start with the evergreen guides that matter most for Financial Services, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full AFL research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Aflac Incorporated, in minutes. 3 free reports included with every account — no credit card required.